{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Unequal access to vaccines\",\"Impact\":\"Prolonged disease spread, social, political, and economic havoc\",\"Mitigation\":\"Improving vaccine equity, prioritizing distribution, investing in local production\",\"Technologies\":\"Vaccine distribution technology, local vaccine production technology\",\"People\":\"Disadvantaged countries, low-income populations\",\"Owner\":\"Global health organizations, governments, pharmaceutical companies\"},{\"Description\":\"Hoarding of vaccines\",\"Impact\":\"Limited access in certain regions, exacerbation of disease spread\",\"Mitigation\":\"Global collaboration, equitable distribution, investment in local solutions\",\"Technologies\":\"Global vaccine distribution technology, local vaccine production technology\",\"People\":\"Disadvantaged regions, particularly Africa\",\"Owner\":\"Global health organizations, governments, pharmaceutical companies\"},{\"Description\":\"Lack of capacity for local vaccine production\",\"Impact\":\"Vulnerability to disease outbreaks, limited access to vaccines\",\"Mitigation\":\"Investing in local production capabilities, technology transfer, research and development\",\"Technologies\":\"Local vaccine production technology, technology transfer programs\",\"People\":\"Countries with limited vaccine production capacity\",\"Owner\":\"Global health organizations, governments, pharmaceutical companies\"}]}"}}